tiprankstipranks
Cara Therapeutics (CARA)
NASDAQ:CARA
Holding CARA?
Track your performance easily

Cara Therapeutics (CARA) Financial Statements

2,262 Followers

Cara Therapeutics Financial Overview

Cara Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.749; its P/E ratio is -0.17; Cara Therapeutics is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue$ 2.56M$ 991.00K$ 2.13M$ 4.87M$ 6.93M
Gross Profit$ 1.54M$ -498.00K$ 1.51M$ 3.31M$ 6.93M
EBIT$ -12.48M$ -20.02M$ -28.71M$ -28.90M$ -31.48M
EBITDA$ -12.16M$ -19.17M$ -28.67M$ -28.84M$ -30.94M
Net Income Common Stockholders$ -12.48M$ -20.02M$ -30.70M$ -28.03M$ -31.48M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 42.04M$ 56.62M$ 69.77M$ 78.54M$ 94.69M
Total Assets$ 51.33M$ 72.50M$ 90.10M$ 115.34M$ 134.39M
Total Debt$ 3.42M$ 7.49M$ 7.04M$ 7.31M$ 982.00K
Net Debt$ -38.62M$ -49.13M$ -62.73M$ -71.23M$ -93.71M
Total Liabilities$ 50.62M$ 60.90M$ 60.30M$ 29.70M$ 25.46M
Stockholders Equity$ 707.00K$ 11.60M$ 29.80M$ 85.64M$ 108.93M
Cash Flow-
Free Cash Flow$ -13.98M$ -12.65M$ -31.29M$ -19.97M$ -20.45M
Operating Cash Flow$ -13.98M$ -12.44M$ -30.45M$ -19.64M$ -20.45M
Investing Cash Flow$ 2.50M$ 15.29M$ 25.95M$ 23.16M$ 32.80M
Financing Cash Flow$ -694.00K$ -610.00K$ -685.00K$ 1.12M-
Currency in USD

Cara Therapeutics Earnings and Revenue History

Cara Therapeutics Debt to Assets

Cara Therapeutics Cash Flow

Cara Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis